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preferential use of sevelamer in dialysis patients cannot
be justified.
WAJEH Y. QUNIBI and CHARLES R. NOLAN
San Antonio, Texas
Correspondence to Wajeh Y. Qunibi, MD, Professor of Medicine,
Medical Director of Dialysis Services, University of Texas Health Sci-
ences Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX
78229-3900.
E-mail: qunibi@uthscsa.edu
REFERENCES
1. MANNS B, STEVENS L, MISKULIN D, et al: A systematic review of seve-
lamer in ESRD and an analysis of its potential economic impact in
Canada and the United States. Kidney Int 66:1239–1247, 2004
2. QUNIBI WY, HOOTKINS RE, MCDOWEL LL, et al: Treatment of hyper-
phosphatemia in hemodialysis patients: The calcium acetate renagel
evaluation (CARE study). Kidney Int 65:1914–1926, 2004
3. NATIONAL KIDNEY FOUNDATION: K/DOQI clinical practice guidelines
for bone metabolism and disease in chronic kidney disease. Am J
Kidney Dis 42(Suppl 3):S1–S202, 2003
4. QUNIBI WY: Consequences of hyperphosphatemia in patients with
end-stage renal disease (ESRD). Kidney Int 66(Suppl 90):S8–S12,
2004
Body mass index and survival
differences in dialysis patients
To the Editor: Stack et al [1] have raised an interesting
question whether obesity may confer a survival advan-
tage or disadvantage in specific dialysis populations. The
authors have demonstrated that, unlike peritoneal dialy-
sis patients (PD), an improved survival is associated with
a greater body mass index (BMI) in hemodialysis patients
(HD) [1]. We wish to offer some supplementary reflec-
tions and suggestions regarding this issue, based on our
experience and practice.
In the general population, an increased BMI is associ-
ated with higher mortality; more properly, total mortality
is a linear increasing function of high fat mass (FM) and
low fat free mass (FFM) [2]. On the contrary, an inverse
BMI-mortality relationship has been reported in HD [3],
although the protective effect of high BMI is limited to pa-
tients with normal or high muscle mass [4]. On the other
hand, a loss of FFM may be undetected if merely BMI is
considered. We observed, in fact, that HD patients with
higher BMI, unlike healthy subjects, show a lower FFM
associated with an increased FM [5] (Table 1).
In PD, peritoneal protein loss, appetite reduction, and
presence of peritonitis may often induce a higher preva-
lence of malnutrition, as compared with HD, and a more
significant loss of FFM. A frequent increase of FM, sec-
ondary to glucose gain, may nevertheless replace the re-
duced FFM without BMI modification. These changes in
body composition, and a more unfavorable lipid profile,
may contribute to the increased mortality in PD patients
with higher BMI.
In conclusion, because BMI cannot differentiate
whether weight change is due to variation of FM or FFM,
BMI must be considered only a limitative predictive fac-
tor for survival analysis in dialysis patients; easy and
noninvasive bodycomposition methods (such as skin-fold
measurements and bioelectrical impedance analysis) are
recommended for a more accurate evaluation of the re-
lationship between BMI and mortality.
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